对子宫内膜异位症的GnRH激素治疗进行权衡:结果和治疗范式
1Obstetrics and Gynecology Department, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Expert opinion on pharmacotherapy
|January 25, 2025
概括
淋巴激素释放激素激动剂 (GnRHa) 可以缓解子宫内膜异位症的疼痛,但有副作用和成本. 个性化治疗是关键,在等待更好的药物时,GnRHa是二线选择.
科学领域:
- 妇科 妇科医生 妇科
- 生殖医学 生殖医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 子宫内膜异位症影响全球10%的女性,导致慢性盆腔疼痛和不孕症.
- 这是一种依赖雌激素的炎症状况,需要有效的管理策略.
研究的目的:
- 审查有关子宫内膜异位症释放激素激动剂 (GnRHa) 的当前文献.
- 评估GnRHa在治疗子宫内膜异位症相关疼痛和不孕症方面的有效性和局限性.
主要方法:
- 用关键词进行文献综述:"GnRHa"",子宫内膜异位症"",不孕症"",慢性盆腔疼痛".
- 随机对照试验 (RCT),系统审查,元分析和国际指南的优先考虑.
主要成果:
- GnRHa可以减少手术后的疼痛和复发,但有副作用和成本.
- 目前关于GnRHa有效性的研究是异质的,没有长期数据.
- 其他选择包括孕激素和口服避孕药,它们可以控制症状,但不能治愈疾病.
结论:
- 个性化药物选择至关重要,考虑到副作用,耐受性,成本和益处.
- 附加治疗的GnRHa是缓解症状的二线选择.
- 子宫内膜异位症的管理需要一种系统的方法,承认复杂的症状病原性.
相关概念视频
Hormonal Regulation of the Menstrual Cycle
277
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
277
Drugs for Treatment of Diarrhea-Predominant IBS
142
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
142
Hormonal Control of the Ovarian Cycle
393
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
393
Ovarian Cycle
954
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
954
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Glucagon-like Receptor Agonists
294
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
294


